Greykasell Wealth Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$803K Buy
3,163
+2
+0.1% +$466 0.29% 75
2026
Q1
$773K Buy
3,161
+125
+4% +$29.1K 0.31% 73
2025
Q4
$628K Buy
3,036
+2
+0.1% +$395 0.25% 86
2025
Q3
$563K Buy
3,034
+155
+5% +$26.6K 0.24% 84
2025
Q2
$440K Sell
2,879
-658
-19% -$101K 0.21% 89
2025
Q1
$587K Buy
3,537
+804
+29% +$126K 0.31% 77
2024
Q4
$395K Buy
+2,733
New +$424K 0.22% 92

Other funds holding JNJ

Greykasell Wealth Strategies's JNJ Position: Q2 2026 in Review

Greykasell Wealth Strategies increased its Johnson & Johnson (JNJ) stake by 0.06% in Q2 2026, buying an estimated $466 and bringing the position to 3,163 shares worth $803K. The position accounts for 0.29% of the portfolio, ranked #75.

Greykasell Wealth Strategies first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Greykasell Wealth Strategies held 3,163 shares of Johnson & Johnson worth $803K as of Q2 2026.
  • Greykasell Wealth Strategies bought 2 Johnson & Johnson shares in Q2 2026, an estimated $466.
  • Johnson & Johnson made up 0.29% of Greykasell Wealth Strategies's portfolio in Q2 2026, its #75 holding.
  • Greykasell Wealth Strategies first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2026, filed 11 Aug 2026.